+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Umbilical Cord Blood Banking Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896802
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Umbilical Cord Blood Banking Market is projected to reach USD 44.86 Billion in 2026. It is expected to continue growing at a CAGR of 17.54%, reaching USD 119.44 Billion by 2032.

Umbilical cord blood banking preserves hematopoietic stem and progenitor cells collected after birth for potential use in allogeneic or autologous transplantation. Since the first successful cord blood transplant in 1988, cord blood has become an established source for hematopoietic stem cell transplantation in selected blood cancers, marrow failure syndromes, inherited immune deficiencies, hemoglobinopathies, and metabolic disorders.

The industry is shaped by rising awareness of newborn stem cell preservation, expanding public cord blood registries, continued private family banking demand, and stricter quality standards from regulators and accreditation bodies such as the U.S. FDA, AABB, FACT, and NetCord. Search demand around cord blood banking, stem cell storage, newborn stem cells, cord blood transplant, and hematopoietic stem cell banking continues to reflect strong consumer and clinical interest.

Transformative Shifts in the Cord Blood Banking Landscape

The cord blood banking landscape is shifting from basic cryogenic storage toward evidence-driven cellular therapy infrastructure. Public banks remain essential for unrelated donor access, especially for patients who lack matched adult donors, while private banks increasingly differentiate through transparent pricing, genetic testing add-ons, dual cord tissue storage, digital family health portals, and long-term sample traceability.

Clinical demand is also evolving as transplant centers refine HLA matching, cell dose selection, double-unit transplantation strategies, and ex vivo expansion approaches designed to address the historically lower cell dose in cord blood units. At the same time, regulatory scrutiny over unproven regenerative claims is increasing, requiring participants to clearly separate established transplant indications from investigational applications in neurology, diabetes, cardiovascular repair, and tissue regeneration.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical operating layer for cord blood banks. AI-enabled analytics can support donor-recipient matching, predict cell viability trends, optimize collection logistics, flag temperature deviations in cryogenic storage, improve inventory utilization across public registries, and strengthen documentation for quality management systems.

The cumulative impact is strongest where AI is paired with validated laboratory data, electronic medical records, high-integrity chain-of-custody systems, and compliant consent workflows. However, AI adoption must align with data privacy laws, explainability expectations, clinical governance, and cybersecurity controls because cord blood banking decisions affect transplant eligibility, long-term storage integrity, regulatory compliance, and family trust.

Key Regional Insights

North America remains a mature cord blood banking region, supported by FDA oversight, AABB and FACT accreditation, established transplant networks, public registry participation, and strong consumer awareness in the United States and Canada. Europe benefits from public banking infrastructure, GDPR-driven data protections, and harmonized tissue and cell quality frameworks under European standards, while the Middle East is expanding family banking through private healthcare investment, medical tourism, and specialized maternal and neonatal care, particularly across GCC markets.

Asia-Pacific shows high long-term potential due to large birth cohorts, rising healthcare spending, expanding stem cell research, and improving biobanking infrastructure in China, India, Japan, South Korea, and Australia. Latin America is advancing through Brazil and Mexico, where transplant capacity, private maternity care, and cord blood banking awareness are improving. Africa remains underpenetrated, with opportunities tied to maternal health access, laboratory investment, cold-chain reliability, clinician education, and regional public-private partnerships that can support equitable access to newborn stem cell preservation.

Key Group Insights

ASEAN markets are gaining attention as urbanization, private maternity care, medical tourism, and expanding middle-income populations increase awareness of newborn stem cell storage. GCC countries are investing in premium family banking, hospital modernization, and advanced healthcare infrastructure, while the European Union provides one of the strongest regulatory environments for tissue traceability, donor consent, quality assurance, data protection, and cross-border oversight of human cells and tissues.

BRICS countries combine large birth populations with expanding biotechnology capacity, making them important for long-term cord blood banking development and clinical research participation. G7 countries lead in transplant standards, accredited laboratory practices, registry integration, and evidence-based clinical governance. NATO member countries, while not a healthcare bloc, generally benefit from resilient medical infrastructure, established biobanking practices, emergency preparedness systems, and cross-border research collaboration that can support quality-focused cord blood banking ecosystems.

Key Country Insights

The United States leads in commercial maturity, FDA-regulated cord blood products, public registry integration, and transplant network depth, while Canada emphasizes public health integration, accredited banking, and equitable donor access. Mexico and Brazil are expanding private banking alongside improving transplant capacity, with Brazil supported by a broad healthcare base and experience in hematopoietic stem cell transplantation across Latin America.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong clinical governance, public banking foundations, tissue and cell quality standards, and established transplant expertise, while Russia has domestic biobanking and transplant activity shaped by national regulation. China and India offer scale through high birth volumes, biotechnology investment, and growing hospital-based awareness; Japan, Australia, and South Korea contribute advanced clinical research, quality systems, digital health adoption, and sophisticated healthcare infrastructure that support evidence-led cord blood banking practices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical credibility by aligning marketing with approved and evidence-based uses of cord blood. Clear consent, transparent storage fees, validated processing methods, robust chain-of-custody documentation, infectious disease screening, and accreditation from recognized bodies improve trust among parents, clinicians, regulators, and payers.

Banks should invest in interoperable digital records, AI-supported quality monitoring, cryogenic risk controls, and partnerships with hospitals, obstetricians, midwives, transplant centers, and public registries. Growth strategies should balance private banking revenue with public health value, especially in ethnically diverse populations where matched donor access remains a documented challenge and cord blood can provide greater HLA-matching flexibility.

Research Methodology

The executive summary is based on secondary research from recognized healthcare, transplant, regulatory, and accreditation sources, including FDA guidance for human cells and tissues, AABB and FACT standards, NetCord practices, public registry information, and peer-reviewed literature on hematopoietic stem cell transplantation and cord blood banking.

The analysis evaluates industry drivers, regulatory conditions, regional healthcare infrastructure, technology adoption, quality standards, and clinical evidence. Insights were cross-checked for consistency with established cord blood banking practices and excluded unsupported claims about unapproved regenerative therapies, market sizing, market share, and market forecasting.

Conclusion

Umbilical cord blood banking is moving from a consumer storage service toward a regulated, data-enabled component of cellular therapy ecosystems. Demand is supported by established transplant use, increasing parental awareness, quality-focused accreditation, and ongoing research into ways to improve stem cell utility and transplant outcomes.

Future competitiveness will depend on quality, compliance, transparency, ethical communication, and responsible innovation. Organizations that combine accredited processing, evidence-based education, AI-enabled operations, secure data governance, and strong clinical partnerships will be best positioned in the global cord blood banking industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Umbilical Cord Blood Banking Market, by Banking Model
7.1. Introduction
7.2. Private
7.3. Public
8. Umbilical Cord Blood Banking Market, by Offerings
8.1. Introduction
8.2. Collection
8.3. Processing
8.3.1. Cell Separation
8.3.2. Viability Testing
8.3.3. Volume Reduction
8.4. Release
8.5. Storage
9. Umbilical Cord Blood Banking Market, by Application
9.1. Introduction
9.2. Blood Disorders
9.2.1. Anemia
9.2.2. Leukemia
9.2.3. Lymphoma
9.3. Immune Disorders
9.4. Metabolic Disorders
9.5. Regenerative Medicine
9.6. Research
10. Umbilical Cord Blood Banking Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals & Clinics
10.4. Research Institutes
11. Umbilical Cord Blood Banking Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Umbilical Cord Blood Banking Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Umbilical Cord Blood Banking Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Banco de Cordon Umbilical S.L.
15.2. Canadian Blood Services
15.3. Cell Care Pty Ltd
15.4. Cells4Life Group LLP
15.5. Cord Blood Registry, LLC
15.6. Cordvida Ltda
15.7. Cryo-Cell International, Inc.
15.8. CryoCenter S.A.
15.9. CryoHoldco LLC
15.10. Future Health Biobank Ltd
15.11. Global Cord Blood Corporation
15.12. LifeCell International Private Limited
15.13. Lifeforce Cryobanks Pvt Ltd
15.14. Macopharma S.A.
15.15. Medipost Co., Ltd.
15.16. National Cord Blood Program
15.17. NeoStem Inc.
15.18. PBKM FamiCord Group
15.19. Redcord S.A.
15.20. Singapore Cord Blood Bank
15.21. Smart Cells International Ltd.
15.22. StemCyte, Inc.
15.23. Stemlife Berhad
15.24. ViaCord, LLC
15.25. Virgin Life Sciences Ltd
15.26. Vita 34 AG
List of Figures
FIGURE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025 VS 2032 (%)
FIGURE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025 VS 2032 (%)
FIGURE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CELL SEPARATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL VIABILITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL VIABILITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL VIABILITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL VOLUME REDUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL VOLUME REDUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL VOLUME REDUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RELEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RELEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RELEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL STORAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL STORAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL STORAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ANEMIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ANEMIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ANEMIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LEUKEMIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL LEUKEMIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL LEUKEMIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LYMPHOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LYMPHOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL LYMPHOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNE DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNE DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNE DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 75. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 77. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 78. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 79. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 80. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 81. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 82. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 84. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 85. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 86. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 87. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 88. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 91. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 92. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 93. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 94. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 95. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 98. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 99. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 100. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 102. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 105. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 106. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 107. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 108. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 109. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 113. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 114. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 115. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 117. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 118. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 120. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 121. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 122. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 124. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 134. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 135. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 136. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 137. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 138. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 141. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 142. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 143. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 145. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 148. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 149. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 150. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 152. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 155. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 156. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 157. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 158. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 160. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 162. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 163. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 164. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 165. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 167. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 169. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 170. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 171. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 172. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 174. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 176. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 177. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 178. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 179. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 181. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 185. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 186. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 188. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 190. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 191. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 192. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 193. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 195. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 197. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 198. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 199. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 200. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 202. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 205. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 206. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 207. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 209. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 211. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 212. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 213. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 214. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 215. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 216. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 219. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 220. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 221. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 222. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 223. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 226. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 227. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 228. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 230. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 233. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 234. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 235. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 237. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 240. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 241. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 242. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 244. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 247. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 248. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 249. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 251. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2017-2032 (USD MILLION)
TABLE 254. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2017-2032 (USD MILLION)
TABLE 255. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 256. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 257. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2017-2032 (USD MILLION)
TABLE 258. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 260. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Banco de Cordon Umbilical S.L.
  • Canadian Blood Services
  • Cell Care Pty Ltd
  • Cells4Life Group LLP
  • Cord Blood Registry, LLC
  • Cordvida Ltda
  • Cryo-Cell International, Inc.
  • CryoCenter S.A.
  • CryoHoldco LLC
  • Future Health Biobank Ltd
  • Global Cord Blood Corporation
  • LifeCell International Private Limited
  • Lifeforce Cryobanks Pvt Ltd
  • Macopharma S.A.
  • Medipost Co., Ltd.
  • National Cord Blood Program
  • NeoStem Inc.
  • PBKM FamiCord Group
  • Redcord S.A.
  • Singapore Cord Blood Bank
  • Smart Cells International Ltd.
  • StemCyte, Inc.
  • Stemlife Berhad
  • ViaCord, LLC
  • Virgin Life Sciences Ltd
  • Vita 34 AG

Table Information